peptide elongation factor 2 has been researched along with Leishmaniasis, Visceral in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dube, A; Jaiswal, AK; Joshi, S; Khare, P; Kushawaha, PK; Sundar, S | 1 |
1 other study(ies) available for peptide elongation factor 2 and Leishmaniasis, Visceral
| Article | Year |
|---|---|
Th1 stimulatory proteins of Leishmania donovani: comparative cellular and protective responses of rTriose phosphate isomerase, rProtein disulfide isomerase and rElongation factor-2 in combination with rHSP70 against visceral leishmaniasis.
Topics: Animals; Antibodies, Protozoan; Antigens, Protozoan; Cricetinae; Female; Gene Expression; HSP70 Heat-Shock Proteins; Immunity, Cellular; Immunization; Leishmania donovani; Leishmaniasis Vaccines; Leishmaniasis, Visceral; Male; Peptide Elongation Factor 2; Protein Disulfide-Isomerases; Protozoan Proteins; Recombinant Proteins; Survival Analysis; Th1 Cells; Triose-Phosphate Isomerase | 2014 |